期刊文献+

Management of hepatitis C infection before and after livertransplantation 被引量:1

下载PDF
导出
摘要 Healthcare systems throughout the world continueto face emerging challenges associated with chronicdisease management. Due to the likely increase inchronic conditions in the future it is now vital thatcooperation and support between specialists, generalistsand primary health care physicians is conducted.Inflammatory bowel disease (IBD) is one such chronicdisease. Despite specialist care being essential, muchIBD care could and probably should be delivered inprimary care with continued collaboration betweenall stakeholders. Whilst most primary care physiciansonly have few patients currently affected by IBD intheir caseload, the proportion of patients with IBDrelatedhealthcare issues cared for in the primarycare setting appears to be widespread. Data suggestshowever, that primary care physician's IBD knowledgeand comfort in management is suboptimal. Currenttreatment guidelines for IBD are helpful but they arenot designed for the primary care setting. Few nonexpertIBD management tools or guidelines existcompared with those used for other chronic diseasessuch as asthma and scant data have been publishedregarding the usefulness of such tools including IBDaction plans and associated supportive literature. Thepurpose of this review is to investigate what nonspecialisttools, action plans or guidelines for IBD arepublished in readily searchable medical literature andcompare these to those which exist for other chronicconditions.
出处 《World Journal of Gastroenterology》 SCIE CAS 2015年第15期4457-4465,共9页 世界胃肠病学杂志(英文版)
  • 相关文献

参考文献1

二级参考文献20

  • 1Johan Burisch,Tine Jess,Matteo Martinato,Peter L. Lakatos.The burden of inflammatory bowel disease in Europe[J].Journal of Crohn’s and Colitis.2013
  • 2Kevin A. Hommel,Elizabeth Hente,Michele Herzer,Lisa M. Ingerski,Lee A. Denson.Telehealth behavioral treatment for medication nonadherence: a pilot and feasibility study[J].European Journal of Gastroenterology & Hepatology.2013(4)
  • 3Richard Wootton.Twenty years of telemedicine in chronic disease management – an evidence synthesis[J].Journal of Telemedicine and Telecare.2012(4)
  • 4Raymond K.Cross,NadiaCheevers,AnkurRustgi,PatriciaLangenberg,JosephFinkelstein.Randomized, controlled trial of home telemanagement in patients with ulcerative colitis (UC HAT)[J].Inflamm Bowel Dis.2012(6)
  • 5Seema Patil,Raymond Cross.Where we’re going, we don’t need appointments: The future of telemedicine in IBD[J].Inflamm Bowel Dis.2012(11)
  • 6C. Sack,V.A. Phan,R. Grafton,G. Holtmann,D.R. van Langenberg,K. Brett,M. Clark,J.M. Andrews.A chronic care model significantly decreases costs and healthcare utilisation in patients with inflammatory bowel disease[J].Journal of Crohn’s and Colitis.2011(3)
  • 7M. Forry,N. Godwin,O. Kelly,G. Harewood,F. Murray,S. Patchett.ON003 From motivated and compliant to empowered: Do we need an IBD nurse led self management programme?[J].Journal of Crohn’s and Colitis.2012
  • 8LaurieKeefer,BethanyDoerfler,CarolineArtz.Optimizing management of Crohn’s disease within a project management framework: Results of a pilot study[J].Inflamm Bowel Dis.2012(2)
  • 9Antonina A. Mikocka‐Walus,Deborah Turnbull,Gerald Holtmann,Jane M. Andrews.An integrated model of care for inflammatory bowel disease sufferers in Australia: Development and the effects of its implementation[J].Inflamm Bowel Dis.2011(8)
  • 10Charles N. Bernstein,Teresa Longobardi,Greg Finlayson,James F. Blanchard.Direct medical cost of managing IBD patients: A Canadian population‐based study[J].Inflamm Bowel Dis.2011(8)

共引文献9

同被引文献28

  • 1.Viral Hepatitis in Liver Transplantation[J].Gastroenterology.2012(6)
  • 2Marina Berenguer.Systematic review of the treatment of established recurrent hepatitis C with pegylated interferon in combination with ribavirin[J].Journal of Hepatology.2008(2)
  • 3Lisa M. Forman,James D. Lewis,Jesse A. Berlin,Harold I. Feldman,Michael R. Lucey.The association between hepatitis C infection and survival after orthotopic liver transplantation[J].Gastroenterology.2002(4)
  • 4Sarah Tischer,Robert J. Fontana.Drug-drug interactions with oral anti-HCV agents and idiosyncratic hepatotoxicity in the liver transplant setting[J]. Journal of Hepatology . 2013
  • 5R. S. Koff.Review article: the efficacy and safety of sofosbuvir, a novel, oral nucleotide NS 5B polymerase inhibitor, in the treatment of chronic hepatitis C virus infection[J]. Aliment Pharmacol Ther . 2014 (5)
  • 6Elizabeth C. Verna,Varun Saxena,James R. Burton,Jacqueline G. O’Leary,Jennifer L. Dodge,Richard T. Stravitz,Josh Levitsky,James F. Trotter,Gregory T. Everson,Robert S. Brown,Norah A. Terrault.Telaprevir- and Boceprevir-based Triple Therapy for Hepatitis C in Liver Transplant Recipients With Advanced Recurrent Disease: A Multicenter Study[J]. Transplantation . 2015 (8)
  • 7Audrey Coilly,Bruno Roche,Jér?me Dumortier,Vincent Leroy,Danielle Botta-Fridlund,Sylvie Radenne,Georges-Philippe Pageaux,Si-Nafaa Si-Ahmed,Olivier Guillaud,Teresa Maria Antonini,Stéphanie Ha?m-Boukobza,Anne-Marie Roque-Afonso,Didier Samuel,Jean-Charles Duclos-Vallée.Safety and efficacy of protease inhibitors to treat hepatitis C after liver transplantation: A multicenter experience[J]. Journal of Hepatology . 2014 (1)
  • 8AASLD.Recommendations for Testing,Managing,and Treating Hepatitis C. . 2014
  • 9Jeong SW,Choi Y,Kim JW.Management of viral hepatitis in liver transplant recipients. Clin Mol Hepatol . 2014
  • 10Lawitz E,Mangia A,Wyles D,et al.Sofosbuvir for previously untreated chronic hepatitis C infection. The New England Journal of Medicine . 2013

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部